Connection

Sheldon Litwin to Cost-Benefit Analysis

This is a "connection" page, showing publications Sheldon Litwin has written about Cost-Benefit Analysis.
Connection Strength

0.035
  1. Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond. Coron Artery Dis. 1999 Sep; 10(6):361-8.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.